XML 21 R11.htm IDEA: XBRL DOCUMENT v3.19.1
Investments
3 Months Ended
Mar. 31, 2019
Investments, Debt and Equity Securities [Abstract]  
Investments
NOTE 5. INVESTMENTS

The following tables summarize the Company’s available-for-sale investments at March 31, 2019 and December 31, 2018 (in thousands):

 
March 31, 2019
 
Amortized
Cost
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Fair Value
Certificates of deposit
$
8,817

$
9

$
(17
)
$
8,809

U.S. Treasury securities
25,401

8

(22
)
25,387

U.S. Agency securities
6,521


(20
)
6,501

Commercial paper
8,463



8,463

Asset-backed securities
4,390

1


4,391

Corporate notes and bonds
22,008

4

(13
)
21,999

Total
$
75,600

$
22

$
(72
)
$
75,550


 
December 31, 2018
 
Amortized
Cost
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Fair Value
Certificates of deposit
$
10,787

$

$

$
10,787

U.S. Treasury securities
22,185

1

(66
)
22,120

U.S. Agency securities
8,024

1

(45
)
7,980

Commercial paper
17,025



17,025

Asset-backed securities
12,007


(9
)
11,998

Corporate notes and bonds
30,361


(53
)
30,308

Total
$
100,389

$
2

$
(173
)
$
100,218



The following table summarizes the maturities of the Company’s available-for-sale securities at March 31, 2019 and December 31, 2018 (in thousands):

 
March 31, 2019
December 31, 2018
 
Amortized
Cost
Fair Value
Amortized
Cost
Fair Value
Due in less than 1 year
$
68,462

$
68,394

$
83,030

$
82,893

Due in 1-3 years
7,138

7,156

17,359

17,325

Total
$
75,600

$
75,550

$
100,389

$
100,218



Proceeds from sales of marketable securities (including principal paydowns) for the three months ended March 31, 2019 and 2018 were $9.0 million and $3.0 million, respectively. The Company determines gains and losses of marketable securities based on specific identification of the securities sold. There were no material realized gains from sales of marketable securities for the three months ended March 31, 2019 and 2018. No material balances were reclassified out of accumulated other comprehensive income (loss) for the three months ended March 31, 2019 and 2018.

The Company monitors investments for other-than-temporary impairment. It was determined that unrealized gains and losses as of March 31, 2019 and December 31, 2018 are temporary in nature because the change in market value for those securities has resulted from fluctuating interest rates rather than a deterioration of the credit worthiness of the issuers. The Company does not intend to sell investments and it is more likely than not that we will not be required to sell investments before recovering the amortized cost.